DiagnOptics receives Health Canada approval for Diab-spot
Groningen, the Netherlands – May 1, 2012
DiagnOptics has received approval from Health Canada for the Diab-spot. This allows the Canadian distributor of the Diab-spot, Bescot Healthcare, to also start the sale of the Diab-spot in Canada besides the already available AGE Reader.
This approval means entry to another important market for DiagnOptics: the diabetes screening market in Canada. Diab-spot offers a noninvasive and convenient method for diabetes screening with an immediate screening result on the spot.
Meest actuele nieuwsberichten
- DiagnOptics receives CE mark approval for AGE Reader mu 2013
- DiagnOptics to show new product at international diabetes meetings in 2013 2012
- AGE Reader presented at German national diabetes conference in Berlin. 2012
- Successful introduction of the AGE Reader mu 2012
- Important role of AGE Reader shown in recent international publications 2012
- DiagnOptics present at the EASD 2012 in Berlin 2012
- DiagnOptics receives Health Canada approval for Diab-spot 2012
- DiagnOptics and PATH partner on project on diabetes screening in India 2012
- DiagnOptics receives CE mark approval for Diab-spot. 2011
- DiagnOptics receives Health Canada approval for the AGE Reader. 2011
Find a distributor in your country. If your country is not listed, please contact DiagnOptics for your enquiries: sales@diagnoptics.com
If you want to receive the newsletter with information about DiagnOptics' products, please send us your email address.
Downloads about the AGE Reader and Diab-spot
- AGE Reader scientific brochure [1549 kb][.pdf]
- Diab-spot brochure NL [337 kb][.pdf]
- IDF prevention consensus DM [281 kb][.pdf]
- Press release ADA AGE Reader [43 kb][.pdf]
- Diab-spot brochure English [874 kb][.pdf]
- AGE Reader product presentation [1455 kb][.pdf]
- Diab-spot product presentation [844 kb][.pdf]
- AGE Reader product brochure NEW! [1046 kb][.pdf]
